Tissue Regenix Group PLC – Unaudited Interim Results
Tissue Regenix Group (AIM:TRX) the regenerative medical devices company today announces its unaudited interim results for the six months ended 30 June 2018.
Tissue Regenix Group (AIM:TRX) the regenerative medical devices company today announces its unaudited interim results for the six months ended 30 June 2018.
Tissue Regenix Group (AIM:TRX) the regenerative medical devices company announces that it has been granted a Human Tissue Authority (HTA) license to import and distribute its’ portfolio of Human tissue derived products from the US for use in the UK market.
Tissue Regenix Group the regenerative medical devices company announces that effective from today it has gained Medicare coverage in an additional 10 States covered by Medicare jurisdiction National Government Services (NGS) for the use of DermaPure®.